Clinical and economic analysis of medicinal prescriptions for children and adolescents with Helicobacter pylori-associated gastroduodenal pathology

Keywords: frequency analysis, ABC-analysis, VEN-analysis, hospital-based treatment, chronic gastritis and/or duodenitis, gastro-esophageal reflux disease, Helicobacter pylori, pharmacoeconomic analysis

Abstract

The significant prevalence of chronic gastritis and/or duodenitis among children and adolescents, the ability of H. pylori to induce serious complications lead to the importance of effective anti-helicobacter therapy.

The aim of the work was to determine the rationality of prescribed drugs and the expediency of financial expenses for pharmacotherapy of chronic gastritis and/or duodenitis associated with H. pylori and gastro-esophageal reflux disease based on the results of a retrospective clinical and economic analysis of medical prescriptions in Dnipro.

The material for the study were the 92 prescription sheets (form No. 003-4/y) of stationary patients aged 5–17 years with a diagnosis of chronic gastritis and/or duodenitis associated with H. pylori and gastro-esophageal reflux disease undergoing treatment at the Dnipropetrovsk Children's City Clinical Hospital № 6 for the period 2012–2017.

Analysis of the prescriptions frequency, their ranking for cost and importance for the treatment were carried out using pharmacoeconomic methods: ABC-, VEN-, frequency analysis and integrated frequency/ABC/VEN analysis.

Frequency analysis of treatment regimens showed that only 47.8% of patients were prescribed a «gold standard» of treatment, while 52.2% of patients had medical prescriptions that did not comply with the national treatment protocols adopted by the Ministry of Health of Ukraine. It was found that in the structure of medical prescriptions for the treatment of chronic gastritis and/or duodenitis associated with H. pylori and GERD, there was excessive use of non-essential drugs «N» (43.9%), which were prescribed almost in the same volume as vital drugs «V» (56.1%).

According to the ABC-analysis, it was established, that the main financial resources were spent on the medicines of six groups: dietary supplements for normalization and maintenance of normal intestinal microflora, omeprazole, mozapride, clarithromycin, domperidone and amoxicillin. It was found, that on average one patient was prescribed 6.6 preparations worth 722.42 UAH.

It can be concluded that the main funds was not spent on the necessary and important medicines for the treatment of the studied nosologies.

References

1. Zvit pro zakhvoriuvannia, zareiestrovani u khvorykh, yaki prozhyvaiut u raioni obsluhovuvannia likuvalno-profilaktychnoho zakladu, za 2017 rik (forma № 12). Zareiestrovano khvorob sered ditei 0–14 rokiv vkliuchno // DZ «Tsentr medychnoi statystyky MOZ Ukrainy». URL: medstat.gov.ua (data zvernennia: 16. 09. 2018).
2. Zvit pro zakhvoriuvannia, zareiestrovani u khvorykh, yaki prozhyvaiut u raioni obsluhovuvannia likuvalno-profilaktychnoho zakladu, za 2017 rik (forma № 12). Struktura i riven poshyrennosti po klasakh khvorob ta okremykh nozolohichnykh formakh sered pidlitkovoho naselennia 15–17 rokiv vkliuchno // DZ «Tsentr medychnoi statystyky MOZ Ukrainy». URL: medstat.gov.ua (data zvernennia: 16. 09. 2018).
3. Unifikovanyi klinichnyi protokol medychnoi dopomohy ditiam iz khronichnym hastro-duodenitom (K-29 za MKKh-10): Nakaz MOZ Ukrainy vid 29. 01. 2013 № 59 «Pro zatverdzhennia unifikovanykh klinichnykh protokoliv medychnoi dopomohy ditiam iz zakhvoriuvanniamy orhaniv travlennia». URL: www.moz.gov.ua (data zvernennia: 20. 09. 2018).
4. Adaptovana klinichna nastanova, zasnovana na dokazakh «Peptychna vyrazka shlunka ta dvanadtsiatypaloi kyshky»: Nakaz MOZ Ukrainy vid 03. 09. 2014 № 613 «Pro zatverdzhennia ta vprovadzhennia medyko-tekhnolohichnykh dokumentiv zi standartyzatsii medychnoi dopomohy pry peptychnii vyraztsi shlunka ta dvanadtsiatypaloi kyshky». URL: http://ukrgastro.com.ua/klinichni-protokoli-ta-nastanovi/ (data zvernennia: 20.09.2018).
5. Lee Y. C., Chiang T. H., Chou C. K. et. al. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis // Gastroenterology. – 2016. – V. 150, N 5. – Р. 1113–1124. https://doi.org/10.1053/j.gastro.2016.01.028.
6. Vnutrishnia medytsyna: pidruchnyk / Za red. M. S. Rasina. – Vinnytsia: Nova Knyha, 2015. – 328 s.
7. Jones N. L., Koletzko S., Goodman K. et. al. ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016) // J. Pediatric Gastroenterol. Nutrition. – 2017. – N 64 (6). – Р. 991–1003. https://doi.org/10.1097/MPG.0000000000001594.
8. Malfertheiner P., Megraud F., O'Morain C. A. et. al. European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter pylori infection – the Maastricht V/Florence Consensus Report // Gut. – 2017. – N 66 (1). – Р. 6–30. https://doi.org/10.1136/gutjnl-2016-312288.
9. Morozov A. M., Yakovlieva L. V., Bezditko N. V. ta in. Otsinka klinichnoi ta ekonomichnoi dotsilnosti vykorystannia likarskykh zasobiv u likuvalno-profilaktychnomu zakladi (suprovid formuliarnoi systemy): Metod. rekomendatsii. – Kyiv, 2013. – 36 s.
10. Unifikovanyi klinichnyi protokol medychnoi dopomohy ditiam iz hastroezofahealnoiu refliuksnoiu khvoroboiu (K-21 za MKKh-10): Nakaz MOZ Ukrainy vid 29. 01. 2013 № 59 «Pro zatverdzhennia unifikovanykh klinichnykh protokoliv medychnoi dopomohy ditiam iz zakhvoriuvanniamy orhaniv travlennia». URL: www.moz.gov.ua. (data zvernennia: 20. 09. 2018).
11. Olkhova I. V., Trokhymchuk V. V. Doslidzhennia arsenalu likarskykh zasobiv dlia likuvannia khvorykh ditei na hastryt i duodenit // Farmats. chasopys. – 2012. – № 4. – S. 114–119.
12. Olkhova I. V., Trokhymchuk V. V. Formuvannia optymalnoho asortymentu likarskykh zasobiv dlia likuvannia ditei, khvorykh na hastryt i duodenit, v umovakh spetsializovanoho statsionaru // Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii. – 2013. – № 2. – S. 81–84.
13. Informatsiino-poshukova systema «Derzhavnyi reiestr likarskykh zasobiv Ukrainy» // Derzhavnyi ekspertnyi tsentr Ministerstva okhorony zdorovia Ukrainy. URL: www.drlz.com.ua (data zvernennia: 10. 09. 2018).
14. Poshukova systema «Serednozvazhena rozdribna vartist likarskykh zasobiv v Ukraini». URL: http://compendium.com.ua/prices (data zvernennia: 10. 09. 2018).
Published
2019-02-12
How to Cite
Makarenko, O. V., Karimova, M. M., & Masheiko, A. M. (2019). Clinical and economic analysis of medicinal prescriptions for children and adolescents with Helicobacter pylori-associated gastroduodenal pathology. Farmatsevtychnyi Zhurnal, (5-6), 11-23. https://doi.org/10.32352/0367-3057.5-6.18.01
Section
Pharmacoeconomics